$REEAF Balance Sheet | Understand Stock

$REEAF

$0.01 -$0.01 (60.0%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Restricted cash
Short-term deposits
Short-term investments
Accounts receivable
Inventory
Other accounts receivable and prepaid expenses
Total current assets

NON-CURRENT ASSETS:
Non-current restricted cash
Other accounts receivable
Deferred transaction costs
Other accounts receivable and prepaid expenses
Operating lease right-of-use assets
Property and equipment, net
Total non-current assets

TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Short term loan
Trade payables
Other accounts payable and accrued expenses
Operating lease liabilities
Total current liabilities
NON-CURRENT LIABILITIES:
Deferred revenues
Warrants liability
Convertible promissory notes
Deferred tax liability
Operating lease liabilities
Total non-current liabilities
TOTAL LIABILITIES
SHAREHOLDERS’ EQUITY:
Ordinary and preferred shares
Ordinary share
Class A Ordinary Shares
Class B Ordinary Shares
Total ordinary share
Additional paid-in capital
Accumulated deficit
Total shareholders’ equity

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Comments